Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4139 Biotechnology

Not Yet Opened 10-08 16:00:00 EDT

83.41

-0.79

-0.94%

High84.14	Low81.80	Vol1.04B
Open84.14	D1 Closing84.20	Amplitude2.79%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O29.36B	T/O Rate--	Tradable Shares0.00
P/B7.886064	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"Biotechnology","latestPrice":83.41436,"timestamp":1791489599999,"preClose":84.20272,"halted":0,"volume":1036051516,"delay":0,"changeRate":-0.009363,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-0.788361,"latestTime":"10-08 16:00:00 EDT","open":84.14293,"high":84.14326,"low":81.79591,"amount":29361498217.420654,"amplitude":0.027877,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791532800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":7.886064,"peRate":-119.861602,"turnoverRate":0.029389,"increases":169,"decrements":332,"flats":13,"marketCap":2119688409607.125,"floatMarketCap":1947030089481.25},"requestUrl":"/m/hq/s/BK4139","defaultTab":"news","newsList":[{"id":"2674887574","title":"Legend Biotech Corporation : JP Morgan Cuts Target Price to $33 from $35","url":"https://stock-news.laohu8.com/highlight/detail?id=2674887574","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674887574?lang=en_us&edition=fundamental","pubTime":"2026-10-09 11:10","pubTimestamp":1791515420,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nFWN45U23Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4505","MEDI","LEGN","BK4588","MEMS","CANC","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674412882","title":"Truist Financial Remains a Buy on BeOne Medicines (ONC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674412882","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674412882?lang=en_us&edition=fundamental","pubTime":"2026-10-09 10:25","pubTimestamp":1791512718,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Gregory Renza from Truist Financial maintained a Buy rating on BeOne Medicines, with a price target of $420.00. Acc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/truist-financial-remains-a-buy-on-beone-medicines-onc-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/truist-financial-remains-a-buy-on-beone-medicines-onc-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","MDCO","ONC","BK4585","BK4139","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674882478","title":"Genmab (GMAB) Receives a Buy from Truist Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2674882478","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674882478?lang=en_us&edition=fundamental","pubTime":"2026-10-09 10:25","pubTimestamp":1791512714,"startTime":"0","endTime":"0","summary":"Truist Financial analyst Gregory Renza maintained a Buy rating on Genmab yesterday and set a price target of $45.00. According to TipRanks, Renza i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/genmab-gmab-receives-a-buy-from-truist-financial-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/genmab-gmab-receives-a-buy-from-truist-financial-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GMAB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674049884","title":"Everest Medicines Appoints Ex-Moderna Executive Lakshmi Srinivasan as Head of Translational Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2674049884","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674049884?lang=en_us&edition=fundamental","pubTime":"2026-10-09 10:13","pubTimestamp":1791512025,"startTime":"0","endTime":"0","summary":"Everest Medicines appoints ex-Moderna executive Lakshmi Srinivasan as head of translational medicineEverest Medicines appointed Lakshmi Srinivasan as senior vice president, head of translational medic","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nNDL9xdVL5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","GNOM","MRNX","BK4568","BK4551","BK1161","MRNY","BK4534","WDNA","BK1574","BK4548","BK4532","BK4501","01952","BK1583","LGHT","MRNA","BK4585","IDNA","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674823408","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2674823408","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674823408?lang=en_us&edition=fundamental","pubTime":"2026-10-09 09:50","pubTimestamp":1791510620,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CSL (CMXHF), Ionis Pharmaceuticals (IONS) and Cormed...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-375?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-375?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","IONS","LU0128526141.USD","XLV","BK4139","CMXHF","BK4585","BK4588","BK4137","HCSG","LU0029874061.USD","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674882317","title":"RBC Capital Remains a Hold on Moderna (MRNA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674882317","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674882317?lang=en_us&edition=fundamental","pubTime":"2026-10-09 09:47","pubTimestamp":1791510478,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Luca Issi maintained a Hold rating on Moderna yesterday and set a price target of $130.00. According to TipRanks, Issi is an an...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-hold-on-moderna-mrna-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-hold-on-moderna-mrna-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","BK4551","LU0128525929.USD","GNOM","BK4139","BK4207","BK4568","IDNA","LU0708994859.HKD","LU1267930573.SGD","LU0029864427.USD","LU0310800379.SGD","BK4534","BK4588","GSIB","MRNA","BK4585","BK4533","LGHT","WDNA","BK4532","BK4501","MRNX","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674888234","title":"Agios Pharma (AGIO) Gets a Hold from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2674888234","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674888234?lang=en_us&edition=fundamental","pubTime":"2026-10-09 09:47","pubTimestamp":1791510452,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Luca Issi maintained a Hold rating on Agios Pharma yesterday and set a price target of $32.00. According to TipRanks, Issi is a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/agios-pharma-agio-gets-a-hold-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/agios-pharma-agio-gets-a-hold-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029864427.USD","LU0708994859.HKD","AGIO","BK4139","BK4207","LU1267930573.SGD","GSIB","LU0128525929.USD","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674392882","title":"Argenx Se (ARGX) Receives a Buy from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2674392882","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674392882?lang=en_us&edition=fundamental","pubTime":"2026-10-09 09:47","pubTimestamp":1791510436,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Luca Issi from RBC Capital maintained a Buy rating on Argenx Se, with a price target of $1,100.00. According to Tip...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/argenx-se-argx-receives-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/argenx-se-argx-receives-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0034235188.USD","LU0390134368.USD","ARGX","GSIB","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4585","LU1267930573.SGD","IE00BJT1NW94.SGD","BK4505","LU2324357040.USD","LU0128525929.USD","LU0029864427.USD","IE00B4R5TH58.HKD","FMED","LU0708994859.HKD","LU0889565916.HKD","TBXU","LU0320765992.SGD","LU1983260115.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","IBB","LU0109394709.USD","IE0009355771.USD","LU0823416689.USD","BK4139","BK4207","LU0310800379.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674886636","title":"Halozyme CEO Helen Torley Disposes of 48,000 Common Shares Worth $5.31 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2674886636","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674886636?lang=en_us&edition=fundamental","pubTime":"2026-10-09 07:57","pubTimestamp":1791503822,"startTime":"0","endTime":"0","summary":"Halozyme CEO Helen Torley disposes of 48,000 common shares worth $5.31 millionHalozyme filed a Form 4 showing President and CEO Helen Torley exercised options for 60,000 shares at $18.41 on Oct. 6-8.S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDL10h7dY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Halozyme CEO Helen Torley Disposes of 48,000 Common Shares Worth $5.31 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","BK4139","FFOX","HALO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674886821","title":"Vertex to Raise Up to C$7 Million in Subordinated Loan with Attached Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2674886821","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674886821?lang=en_us&edition=fundamental","pubTime":"2026-10-09 07:38","pubTimestamp":1791502698,"startTime":"0","endTime":"0","summary":"An update from Vertex Resource Group Ltd. ( ($TSE:VTX) ) is now available. Vertex Resource Group Ltd., a North American environmental services firm...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-to-raise-up-to-c7-million-in-subordinated-loan-with-attached-warrants?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-to-raise-up-to-c7-million-in-subordinated-loan-with-attached-warrants?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1035775433.USD","LU0432979614.USD","BK4585","IE00BJT1NW94.SGD","LU1093756168.USD","SG9999001176.USD","LU1674673428.USD","LU2362541513.USD","IE00B19Z9P08.USD","IE00B19Z3581.USD","LU2362541273.HKD","IBBQ","LU1778281490.HKD","BIB","LU0256863811.USD","LU0757428866.USD","LU1430594728.SGD","TBXU","LU0823416689.USD","LU2417539215.USD","BK4532","VRTX","IDNA","IE00B894F039.SGD","LU2237438978.USD","BBH","BK4567","IE00B19Z3B42.SGD","PBE","IE00B4R5TH58.HKD","LU1815336091.USD","LU0058720904.USD","LU0417517546.SGD","IE00B2B36J28.USD","LU1559883803.SGD","SGXZ57979304.SGD","GNMX","SG9999013999.USD","LU2089984988.USD","BK4588","LU2462157665.USD","LU2456880835.USD","BK4139","IE0009355771.USD","IBB","VERX","IE0002141913.USD","LU0061475181.USD","LU0566484027.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674988599","title":"Ideaya Biosciences CEO Yujiro S. Hata Disposes of $986,768 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2674988599","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674988599?lang=en_us&edition=fundamental","pubTime":"2026-10-09 07:04","pubTimestamp":1791500661,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences CEO Yujiro S. Hata disposes of $986,768 in common sharesIDEAYA Biosciences President and CEO Yujiro S. Hata cut his direct stake to 690,695 common shares on Oct. 6, 2026.Change foll","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDL5B145Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Ideaya Biosciences CEO Yujiro S. Hata Disposes of $986,768 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674841885","title":"Mesoblast Limited (MEOBF) Receives a Buy from Bell Potter","url":"https://stock-news.laohu8.com/highlight/detail?id=2674841885","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674841885?lang=en_us&edition=fundamental","pubTime":"2026-10-09 06:35","pubTimestamp":1791498922,"startTime":"0","endTime":"0","summary":"Bell Potter analyst John Hester maintained a Buy rating on Mesoblast Limited today and set a price target of A$4.45. Hester covers the Healthcare s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mesoblast-limited-meobf-receives-a-buy-from-bell-potter-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mesoblast-limited-meobf-receives-a-buy-from-bell-potter-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4581","MEOBF","BK4585","XBI","BK4588","BK4139","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674883067","title":"Press Release: Vertex Resource GROUP LTD. Announces Subordinated TERM LOAN of up to C$7,000,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2674883067","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674883067?lang=en_us&edition=fundamental","pubTime":"2026-10-09 06:30","pubTimestamp":1791498600,"startTime":"0","endTime":"0","summary":"SHERWOOD PARK, AB, Oct. 8, 2026 /CNW/ -- (TSXV: VTX) -- Vertex Resource Group Ltd. (\"Vertex\" or the \"Corporation\") announces its intention to enter into a subordinated credit arrangement with Factory ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0432979614.USD","LU1674673691.USD","LU1674673428.USD","IBBQ","IE00B4R5TH58.HKD","SG9999001176.SGD","91013","BBH","IE00B19Z9Z06.USD","LU2462157665.USD","LU0889565916.HKD","VRTX","LU0061475181.USD","BK4567","LU1093756325.SGD","LU2362540622.SGD","IDNA","IE00BJT1NW94.SGD","LU2237438978.USD","IE0002141913.USD","BK4585","LU0289739699.SGD","BK4533","LU1778281490.HKD","LU2417539215.USD","VERX","PBE","BK4588","LU0079474960.USD","LU2362541273.HKD","SG9999001176.USD","TBXU","91512","IE0009355771.USD","LU0320765992.SGD","LU1585245621.USD","SGXZ57979304.SGD","IE00B894F039.SGD","IE0002270589.USD","GNMX","BIB","IBB","BK4139","LU0757428866.USD","LU2468319806.SGD","SG9999013999.USD","IE00BZ9MQY76.HKD","LU0109394709.USD","LU2456880835.USD","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674883808","title":"Crispr Therapeutics General Counsel James R. Kasinger Disposes of 1,990 Common Shares Worth $119,481.19","url":"https://stock-news.laohu8.com/highlight/detail?id=2674883808","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674883808?lang=en_us&edition=fundamental","pubTime":"2026-10-09 05:35","pubTimestamp":1791495338,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics General Counsel James R. Kasinger disposes of 1,990 common shares worth $119,481.19James R. Kasinger, general counsel and secretary, exercised stock options for 1,990 common shares","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDL65MQgW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Crispr Therapeutics General Counsel James R. Kasinger Disposes of 1,990 Common Shares Worth $119,481.19","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","LU1861558580.USD","ARKG","BK4611","CRSP","BK4139","BK4556","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674088807","title":"FF EAI Robotics Ecosystem to Present at ThinkEquity Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2674088807","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674088807?lang=en_us&edition=fundamental","pubTime":"2026-10-09 05:30","pubTimestamp":1791495029,"startTime":"0","endTime":"0","summary":"FF EAI Robotics Ecosystem to present at ThinkEquity ConferenceFF EAI Robotics Ecosystem will attend the ThinkEquity Conference on Oct. 15, 2026, at the Mandarin Oriental in New York.CEO Jerry Wang is ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDL6GmNqM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FFR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674888042","title":"Relay Therapeutics CFO Thomas Catinazzo Sells $329,202 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2674888042","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674888042?lang=en_us&edition=fundamental","pubTime":"2026-10-09 05:29","pubTimestamp":1791494997,"startTime":"0","endTime":"0","summary":"Relay Therapeutics CFO Thomas Catinazzo sells $329,202 in common sharesRelay Therapeutics CFO Thomas Catinazzo sold 17,717 common shares on Oct. 6, 2026.Sales priced at USD 18.58 and USD 19.26 per sha","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDLDZNj8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Relay Therapeutics CFO Thomas Catinazzo Sells $329,202 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLAY","BK4563","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674888046","title":"United Therapeutics Chairperson, CEO Martine Rothblatt Disposes of USD 4.88 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2674888046","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674888046?lang=en_us&edition=fundamental","pubTime":"2026-10-09 05:29","pubTimestamp":1791494988,"startTime":"0","endTime":"0","summary":"United Therapeutics Chairperson, CEO Martine Rothblatt disposes of USD 4.88 million in common sharesUnited Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 share","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDL8pdq4t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"United Therapeutics Chairperson, CEO Martine Rothblatt Disposes of USD 4.88 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1699723380.USD","LU1571399168.USD","BK4139","UTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674188808","title":"Propanc Biopharma Files Draft Information Statement for Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2674188808","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674188808?lang=en_us&edition=fundamental","pubTime":"2026-10-09 05:26","pubTimestamp":1791494788,"startTime":"0","endTime":"0","summary":"Propanc Biopharma files draft information statement for reverse stock splitPropanc Biopharma shareholders authorized a reverse stock split of common stock within a 1-for-2 to 1-for-10 range.Share coun","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDL4Zjd1Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPCB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674888068","title":"Novavax Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2674888068","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674888068?lang=en_us&edition=fundamental","pubTime":"2026-10-09 05:26","pubTimestamp":1791494760,"startTime":"0","endTime":"0","summary":"DJ Novavax Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  slid 1.87% to $11.01 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.10% to 51,231.64 and the NASDAQ Composite Index  falling 1.25% to 27,193.34.This was the stock's third consecutive day of losses.Novavax Inc. closed 17.74% short of its 52-week high of $13.39, which the company reached on October 5th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 0.76% to $256.48, Pfizer Inc.  fell 0.64% to $27.82, and Merck & Co. Inc.  fell 0.29% to $142.38.Trading volume  eclipsed its 50-day average volume of 5.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 8, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX","BK4588","BK4585","BK4568","BK4139","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674884708","title":"FibroBiologics Enters USD 1.2 Million Convertible Debenture Deal with Peak One Opportunity Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=2674884708","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674884708?lang=en_us&edition=fundamental","pubTime":"2026-10-09 05:16","pubTimestamp":1791494173,"startTime":"0","endTime":"0","summary":"FibroBiologics enters USD 1.2 million convertible debenture deal with Peak One Opportunity FundFibroBiologics entered a securities purchase agreement with Peak One Opportunity Fund for a USD 1.2 milli","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDL3KTsZp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0104},{"period":"3month","weight":0.0251},{"period":"6month","weight":0.139},{"period":"1year","weight":0.1498},{"period":"ytd","weight":0.1349}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4139","nameEN":"BK4139"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biotechnology(BK4139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biotechnology,BK4139,Biotechnology股票,Biotechnology股票老虎,Biotechnology股票老虎国际,Biotechnology行情,Biotechnology股票行情,Biotechnology股价,Biotechnology股市,Biotechnology股票价格,Biotechnology股票交易,Biotechnology股票购买,Biotechnology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biotechnology(BK4139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}